UniQure NV - Company Profile
Powered by
All the data and insights you need on UniQure NV in one report.
- Save hours of research time and resources with
our up-to-date UniQure NV Strategy Report
- Understand UniQure NV position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
UniQure NV (UniQure) is a biopharmaceutical company that provides gene therapy-based treatments for patients with severe genetic and orphan diseases. Collaboration, focus on research and development, and gene therapy platform are its strengths, even as a declining operational performance is a major cause for concern to the company. The market potential of regulatory approval and hemophilia treatment, and strategic contracts and agreements could provide growth opportunities for the company. However, rapid technological changes, stiff competition, and stringent regulations could hamper its growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer